Related Experiment Video

Updated: Jul 13, 2025

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

5.7K

[Intensification and Personalization of Neoadjuvant Therapy for Locally Advanced Rectal Cancer]

Ralph Fritsch, Chiara Louisa Hempel

    Praxis
    |October 12, 2023
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
    09:11

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

    Published on: May 24, 2024

    487
    Retzius-Sparing Robot-Assisted Radical Prostatectomy
    12:10

    Retzius-Sparing Robot-Assisted Radical Prostatectomy

    Published on: May 19, 2022

    7.8K

    Related Experiment Videos

    Last Updated: Jul 13, 2025

    Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
    12:45

    Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

    Published on: February 12, 2022

    5.7K
    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
    09:11

    Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

    Published on: May 24, 2024

    487
    Retzius-Sparing Robot-Assisted Radical Prostatectomy
    12:10

    Retzius-Sparing Robot-Assisted Radical Prostatectomy

    Published on: May 19, 2022

    7.8K

    Related Concept Videos

    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    4.9K
    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    4.9K
    Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

    Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

    171
    Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
    171

    Articles linked to this work by shared authors, journal, and citation graph.

    Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis.

    Journal of the National Cancer Institute·2026

    Aurora kinase A is a synthetic lethal target in FANCA-deficient cancers.

    NPJ precision oncology·2026

    Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysis.

    Hepatobiliary surgery and nutrition·2026

    Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis.

    Annals of surgical oncology·2026

    Ablatio-bilica: safety of biliary intraductal radiofrequency ablation in patients with unresectable extrahepatic biliary tract cancer undergoing systemic anti-tumor therapy: a phase II, multi-center, randomized, and controlled study.

    Frontiers in oncology·2026

    Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms.

    The Journal of clinical endocrinology and metabolism·2026

    [10 Things Cardiologists Need to Know About Cardiac Amyloidosis].

    Praxis·2026

    [Exertional dyspnea in the elderly - interpretation of an incidental finding].

    Praxis·2026

    [Bullous eruption in the elderly - a case report with diagnostic challenges].

    Praxis·2026

    [Immobilizing back pain in an elderly patient: Differential diagnostic considerations and diagnosis].

    Praxis·2026

    [Fulminant blood sugar increase - a rare but life-threatening course].

    Praxis·2026

    [Dyslipidaemia guideline issued by the Department of Internal Medicine (DIM) at the University Hospital Zurich (USZ)].

    Praxis·2026

    Circular RNA MCM3 recruits USP49 to stabilize PTBP1 and promote cisplatin resistance in cervical squamous cell carcinoma.

    Oncogene·2026

    Fourier-based chemometric resolution of the FOLFOX regimen through digital filtering with poly-metric sustainability assessment.

    Scientific reports·2026

    Self-Enhancing Photodynamic / Immunotherapy via a MOF Nanoplatform for Combined STING Activation and Immune Checkpoint Blockade.

    Advanced healthcare materials·2026

    Comparative effectiveness and safety of carotid endarterectomy, carotid stenting, and optimal medical therapy across symptomatic and asymptomatic carotid stenosis: An updated network meta-analysis of randomized controlled trials.

    Cardiovascular revascularization medicine : including molecular interventions·2026

    Feasibility and Characterization of Immune-related Pathologic Response Criteria in Renal Cell Carcinoma.

    European urology oncology·2026

    Digitally enabled patient-centred survivorship care: from hype to implementation-aware impact.

    The Lancet. Digital health·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us